About Us | Contact

Cory Anderson Investigator

NPI1720050727
Update NPI

Open Payments

Note

The following payment details are based on a national transparency program known as the Sunshine Act that collects and publishes information about financial relationships between the health care industry (i.e. drug and device manufactures) and providers. These relationships may involve payment to providers for things such as research, speaking engagment, travel, gifts etc. Not all of these payment involve monetary compensations and may include batering of drugs or devices.

Total Payment Worth

$9,509.96
from 53 payments in the last 6 years

Total Cash or Cash Equivalent

$2,289.15
from 9 payments in the last 6 years

Total In-kind Items & Services

$7,220.81
from 44 payments in the last 6 years

Nature of Payments

Last 6 Years
Chart will render here...

Yearly Breakdown

Chart will render here...

Payment Details

Date Payment Type Form of Payment Item/Service Payment Amount
09/25/2021 General (Non-Research) In-kind items and services Food and Beverage $12.86 Details
Payment from Abbott Laboratories
Payment Record ID 833660383
09/25/2021 General (Non-Research) In-kind items and services Food and Beverage $12.87 Details
Payment from Abbott Laboratories
Payment Record ID 833660381
06/03/2021 General (Non-Research) In-kind items and services Gift $20.00 Details
Payment from PFIZER INC.
Payment Record ID 833592629
09/27/2021 Research In-kind items and services $884.05 Details
Payment from Eli Lilly and Company
Paymment Research Study A MASTER PROTOCOL FOR RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 CLINICAL TRIALS OF MULTIPLE INTERVENTIONS FOR THE TREATMENT OF CHRONIC PAIN
Clinical Trials Gov ID NCT05080660
Payment Record ID 819443915
02/11/2021 Research In-kind items and services $16.34 Details
Payment from Eli Lilly and Company
Paymment Research Study A PHASE 3, 12 MONTH, OPEN LABEL STUDY OF LASMIDITAN IN PEDIATRIC PATIENTS WITH MIGRAINE PIONEER PEDS2
Clinical Trials Gov ID NCT04396574
Payment Record ID 819443851
01/29/2021 Research In-kind items and services $99.06 Details
Payment from Eli Lilly and Company
Paymment Research Study PEDIATRIC OPTIONS FOR MIGRAINE RELIEF A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED STUDY OF LASMIDITAN FOR ACUTE TREATMENT OF MIGRAINE PIONEER PEDS1
Clinical Trials Gov ID NCT04396236
Payment Record ID 819443775
06/30/2021 Research In-kind items and services $813.00 Details
Payment from Eli Lilly and Company
Paymment Research Study RANDOMIZED, PLACEBO CONTROLLED, PHASE 2 CLINICAL TRIAL TO EVALUATE LY3556050 FOR THE TREATMENT OF OSTEOARTHRITIS PAIN
Clinical Trials Gov ID NCT04627038
Payment Record ID 819443721
06/28/2021 Research In-kind items and services $272.68 Details
Payment from Eli Lilly and Company
Paymment Research Study THE EFFECT OF TIRZEPATIDE VERSUS DULAGLUTIDE ON MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES (SURPASS CVOT)
Clinical Trials Gov ID NCT04255433
Payment Record ID 819443145
02/06/2020 General (Non-Research) In-kind items and services Food and Beverage $19.74 Details
Payment from Shionogi Inc
Payment Record ID 750204909
02/06/2020 General (Non-Research) In-kind items and services Food and Beverage $46.06 Details
Payment from Shionogi Inc
Payment Record ID 750204907
02/06/2020 General (Non-Research) In-kind items and services Food and Beverage $17.11 Details
Payment from Shionogi Inc
Payment Record ID 750204905
02/06/2020 General (Non-Research) In-kind items and services Food and Beverage $19.74 Details
Payment from Shionogi Inc
Payment Record ID 750204903
02/07/2020 General (Non-Research) In-kind items and services Travel and Lodging $40.00 Details
Payment from Shionogi Inc
Payment Record ID 750204901
02/05/2020 General (Non-Research) In-kind items and services Travel and Lodging $40.00 Details
Payment from Shionogi Inc
Payment Record ID 750204899
02/05/2020 General (Non-Research) In-kind items and services Travel and Lodging $304.90 Details
Payment from Shionogi Inc
Payment Record ID 750204897
02/05/2020 General (Non-Research) In-kind items and services Travel and Lodging $200.00 Details
Payment from Shionogi Inc
Payment Record ID 750204895
06/17/2020 Research In-kind items and services $536.85 Details
Payment from Eli Lilly and Company
Paymment Research Study PEDIATRIC OPTIONS FOR MIGRAINE RELIEF A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED STUDY OF LASMIDITAN FOR ACUTE TREATMENT OF MIGRAINE PIONEER PEDS1
Clinical Trials Gov ID NCT04396236
Payment Record ID 728718329
06/12/2020 Research In-kind items and services $180.36 Details
Payment from Eli Lilly and Company
Paymment Research Study A PHASE 3, 12 MONTH, OPEN LABEL STUDY OF LASMIDITAN IN PEDIATRIC PATIENTS WITH MIGRAINE PIONEER PEDS2
Clinical Trials Gov ID NCT04396574
Payment Record ID 728718201
07/12/2019 General (Non-Research) In-kind items and services Food and Beverage $349.98 Details
Payment from PFIZER INC.
Payment Record ID 672599293
07/12/2019 General (Non-Research) In-kind items and services Travel and Lodging $98.17 Details
Payment from PFIZER INC.
Payment Record ID 672599289
07/12/2019 General (Non-Research) In-kind items and services Travel and Lodging $432.29 Details
Payment from PFIZER INC.
Payment Record ID 672599285
07/12/2019 General (Non-Research) In-kind items and services Travel and Lodging $196.15 Details
Payment from PFIZER INC.
Payment Record ID 672599281
08/27/2019 General (Non-Research) In-kind items and services Travel and Lodging $173.26 Details
Payment from PFIZER INC.
Payment Record ID 672597117
12/11/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $150.00 Details
Payment from COMSORT, Inc
Payment Record ID 604789881
01/11/2018 General (Non-Research) In-kind items and services Travel and Lodging $110.46 Details
Payment from AstraZeneca UK Limited
Payment Record ID 562310341
01/11/2018 General (Non-Research) In-kind items and services Travel and Lodging $83.13 Details
Payment from AstraZeneca UK Limited
Payment Record ID 562060108
01/11/2018 General (Non-Research) In-kind items and services Travel and Lodging $680.00 Details
Payment from AstraZeneca UK Limited
Payment Record ID 562003703
01/11/2018 General (Non-Research) In-kind items and services Food and Beverage $83.36 Details
Payment from AstraZeneca UK Limited
Payment Record ID 561895799
01/11/2018 General (Non-Research) In-kind items and services Food and Beverage $109.63 Details
Payment from AstraZeneca UK Limited
Payment Record ID 561518770
01/11/2018 General (Non-Research) In-kind items and services Travel and Lodging $302.86 Details
Payment from AstraZeneca UK Limited
Payment Record ID 561253641
01/11/2018 General (Non-Research) In-kind items and services Food and Beverage $71.99 Details
Payment from AstraZeneca UK Limited
Payment Record ID 561171269
01/11/2018 General (Non-Research) In-kind items and services Food and Beverage $133.90 Details
Payment from AstraZeneca UK Limited
Payment Record ID 561122789
01/11/2018 General (Non-Research) In-kind items and services Food and Beverage $42.55 Details
Payment from AstraZeneca UK Limited
Payment Record ID 560491209
03/06/2018 General (Non-Research) In-kind items and services Travel and Lodging $120.00 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 560458995
01/11/2018 General (Non-Research) In-kind items and services Food and Beverage $106.61 Details
Payment from AstraZeneca UK Limited
Payment Record ID 559878073
01/11/2018 General (Non-Research) In-kind items and services Food and Beverage $41.43 Details
Payment from AstraZeneca UK Limited
Payment Record ID 559718711
04/27/2017 Research Cash or cash equivalent $500.00 Details
Payment from Glenmark Pharmaceuticals Inc.
Paymment Research Study GSP304-201
Payment Record ID 494593241
04/27/2017 Research Cash or cash equivalent $37.02 Details
Payment from Glenmark Pharmaceuticals Inc.
Paymment Research Study GSP304-201
Payment Record ID 494593237
04/27/2017 Research Cash or cash equivalent $19.06 Details
Payment from Glenmark Pharmaceuticals Inc.
Paymment Research Study GSP304-201
Payment Record ID 494593231
04/27/2017 Research Cash or cash equivalent $17.98 Details
Payment from Glenmark Pharmaceuticals Inc.
Paymment Research Study GSP304-201
Payment Record ID 494593229
04/27/2017 Research Cash or cash equivalent $0.40 Details
Payment from Glenmark Pharmaceuticals Inc.
Paymment Research Study GSP304-201
Payment Record ID 494593223
03/06/2017 Research Cash or cash equivalent Drug $172.10 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A Phase IIb, 24 week, randomized, double blind, 3 arm parallel group study, comparing the efficacy, safety and tolerability of two doses of umeclidinium bromide administered once daily via a dry powder inhaler, versus placebo, in participants with asthma
Payment Record ID 478880919
02/24/2017 Research Cash or cash equivalent Drug $774.60 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A Phase IIb, 24 week, randomized, double blind, 3 arm parallel group study, comparing the efficacy, safety and tolerability of two doses of umeclidinium bromide administered once daily via a dry powder inhaler, versus placebo, in participants with asthma
Payment Record ID 478880911
05/31/2017 General (Non-Research) In-kind items and services Travel and Lodging $216.43 Details
Payment from AstraZeneca UK Limited
Payment Record ID 446404483
06/01/2017 General (Non-Research) In-kind items and services Travel and Lodging $50.97 Details
Payment from AstraZeneca UK Limited
Payment Record ID 446386403
06/01/2017 General (Non-Research) In-kind items and services Food and Beverage $52.06 Details
Payment from AstraZeneca UK Limited
Payment Record ID 445825201
05/31/2017 General (Non-Research) In-kind items and services Travel and Lodging $86.07 Details
Payment from AstraZeneca UK Limited
Payment Record ID 445646035
06/01/2017 General (Non-Research) In-kind items and services Food and Beverage $39.54 Details
Payment from AstraZeneca UK Limited
Payment Record ID 445620843
07/25/2017 General (Non-Research) Cash or cash equivalent Travel and Lodging $617.99 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 445529651
06/01/2017 General (Non-Research) In-kind items and services Food and Beverage $60.19 Details
Payment from AstraZeneca UK Limited
Payment Record ID 445204525
06/27/2016 General (Non-Research) In-kind items and services Food and Beverage $17.06 Details
Payment from Allergan Inc.
Payment Record ID 378711012
09/20/2016 General (Non-Research) In-kind items and services Food and Beverage $15.18 Details
Payment from Allergan Inc.
Payment Record ID 378710982
10/11/2016 General (Non-Research) In-kind items and services Food and Beverage $11.92 Details
Payment from Allergan Inc.
Payment Record ID 378710948
;